title: [Management of refractory neuroblastoma with high-dose topotecan plus cyclophosphamide and vincristine].
authors.affiliation: Department of Pediatric Hematology and Oncology, First Hospital of Jilin University, Changchun, Jilin 130021, China.
authors.forename: Jian
authors.initials: J
authors.lastname: Chang
authors.forename: Yu-Tong
authors.initials: YT
authors.lastname: Zhang
authors.forename: Li-Zhe
authors.initials: LZ
authors.lastname: Wang
authors.forename: Xiao-Dan
authors.initials: XD
authors.lastname: Zhong
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D009447:Neuroblastoma / Q000188:drug therapy*; D019772:Topotecan / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D019772:Topotecan; D003520:Cyclophosphamide